The pharmaceutical industry is constantly undergoing change and is on the brink of entering a new phase. A series of forces are working behind this drastic shift in the industry. These driving forces have had an impact on pharmaceutical careers and jobs. These can be classified into the following groups:

Revenue Generation is obviously one of the key factors that need to be considered. There is an issue that most pharmaceutical companies face, that of expiring patents. They have to depend on a particular number of drugs for much of the revenue generation and increase their profitability. However, most of the patents on specific treatments expire within the next decade.

The process of new drug development does not appear to hold much promise as far as revenue generation is concerned. The new drugs will obviously not end up generating as much income as the medicines that are already in the market for a substantial period of time.

There have been a number of mergers in the industry and this has created some powerful players in the industry. In the past, doctors played the role of decision makers in the field, but in the current context, the established pharmaceutical companies certainly turn out to be the powerful players. These organisations thus play an influential role in the industry.

Then there are the low cost medications that include treatments and generic medications that are sold to the pharmaceutical companies at an extremely low rate. Pharmaceutical companies thus face the unpleasant choice of offering discounts on branded medications.

The price and the risks associated with the development of new drugs have increased substantially. The pressure of the revenues generated thus has increased considerably. The risk and the cost associated with the development of the new
medicines have shot up for a number of reasons.

Several drugs that are been developed these days are directed towards curing particular health conditions that are difficult and complicated. Thus, the amount of research and time required for the development of such a drug has increased manifold and thus reduced the chances of acquiring success in quick time.

In the past, the research and development activities were more or less governed by diverse commercial applications. The research activities, these days, are determined by scientific discoveries.

Also, the process of regulatory approval has become extremely costly and complex. The regulatory agencies have turned out to be extremely sophisticated and conservative in the evaluation of the drugs, much more caution than they have ever been in the past. Obviously, the approval standards have also risen significantly. This implies that pharmaceutical companies are carrying out the test of new treatments in costly and comprehensive clinical trials. In fact, people from diverse sectors are absorbed in the field and this includes professionals from medical information jobs.

Payers are gradually shifting to an “outcomes-based” analysis of the treatment alternatives. Therefore, it has become difficult to predict the potential revenue that might be generated from new treatments.

Globalisation has also emerged as a powerful force that has affected the dynamics of the industry. So far, the European Union and the United States has been the centre of the pharmaceutical business. However, in the recent years, there has been a gradual shift in the core area of business as more and more Asian and other countries have joined the fray.

Author Bio: Steven Hayes works as a recruitment professional. He has published a number of articles on the prospect of pharmaceutical careers. You can seek his advice while applying for a job in the field.